Mind Medicine (MindMed) Inc N.MMED.WR

Primary Symbol: MNMD Alternate Symbol(s): N.MMED.WS | N.MMED.WA | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > Riskier stocks

<< Previous

Bullboard Posts

Next >>

Comment by Nicksonsnowboaron Nov 29, 2021 12:18pm

245 Views

Post# 34176141

RE:RE:RE:Riskier stocks

Yep buy mid way through and sell on the hype. It's a gimmick stock, smart money is out . Long term holders on a product that has no value just goingwatch it go down. They are years away from possibly producing some results . Then government approval,heck they won't even legalize weed . They are just living off your money. By the way it doesn't cost anything to watch. Good luck.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments